2026 International Congress Archives - Page 78 of 208

Machine Learning for Early Detection of Huntington’s Disease: Integrating Non-Motor Symptoms and Gender-Specific Differences

S. Rajput, P. Tiwari, S. Sinha (Delhi, India)
Machine Learning-Based Frequency-Domain Analysis of Gait Acceleration for Huntington’s Disease Detection

R. Kumar, S. Choudhary, M. Singh (Pharmacology, India)
Machine Learning-Driven Analysis of Epigenetic Signatures in Juvenile Huntington’s Disease: Investigating Histone Modification Dynamics

R. Kumar, S. Choudhary, M. Singh (Pharmacology, India)
Machine Learning–Based Brain Age Modeling Reveals Accelerated Structural Degeneration in Parkinson’s Disease

ZK. Liu, BX. Liu, MJ. Fang, N. Zhou, RT. Li, LC. He, ZT. Hu, WH. Li (Beijing, China)
Macrophage Subtypes in Brainstem Catecholamine Regions in Healthy Ageing and Across Parkinson’s Disease.

A. Filimontseva, S. Gonzalez, Y. Fu, G. Halliday (Chevy Chase, USA)
Magnitude of Non-Motor Symptoms Among People with Parkinson’s Disease in Rural and Urban Tanzania

B. Mushengezi, K. Okeng'O, R. Walker, M. Mng'Ong'O, E. Massawe, M. Dekker, N. Okubadejo, P. Adebayo, N. Fothergill-Misbah, Y. Okkaoglu, S. Urasa (Dar es Salaam, United Republic of Tanzania)
Manganese-induced neurotoxicity and Parkinsonian-like syndrome: potential protective role of Opuntia ficus-indica cladode extract in rats

H. Harifi, I. Chatterjee, L. Bikjdaouene (Kenitra, Morocco)
Mapping Intrinsic Brain Network Connectivity Using Resting-State Functional MRI In Spinocerebellar Ataxia 12 In Comparison with Healthy Controls

P. Pankaj, M. Kumar, S. Kumaran, A. Srivastava, A. Garg, R. Agrawal, A. Nehra, R. Rajan (New Delhi, India)
Mapping the Temporal Evolution of Non-Motor Symptoms in Parkinson’s Disease: Findings from 100 Outpatient Cases Using a Single-Page Temporal Template

F. Madathum Kuzhiyil, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Marked intrafamilial phenotypic variability in VPS13A disease: a case series of three siblings

S. Rampes, A. Batla (Luton, United Kingdom)
Markerless Kinematic Analysis of Gait and Turning in Parkinson’s Disease

A. Tahara, A. Chinaglia, R. Monteiro, L. Santos, P. Santiago (Ribeirão Preto, Brazil)
Markerless Kinematics of Levodopa Response During Activities of Daily Living in Parkinson’s Disease

J. Yun, S. Haar (London, United Kingdom)
Mass balance and metabolism of BIA 28-6156, an allosteric activator of beta-glucocerebrosidase, in humans

A. Loureiro, A. Ronaghinia, F. Sousa, D. Almeida, R. Costa, J. Holenz, M. Bonifácio (Coronado, Portugal)
MDS Guidance Framework for Electronic Clinical Outcome Assessments: Updating Practices for Validation and Implementation

R. Fuller, M. Skorvanek, M. Monje, M. Tosin, T. Turner, S. Ali, A. Lane, A. Sanchez Ferro, T. Mestre (Princeton, USA)
MDS-UPDRS Part III Cannot Be Reliably Reduced for Prognostic Modeling in Early Parkinson’s Disease

M. Alam, G. Stebbins, T. Mestre, C. Goetz, S. Luo (Durham, USA)
MDSGene literature update on autosomal recessive Parkinson’s Disease

T. Kleinz, M. Thomsen, S. Schaake, H. Madoev, M. Doquenia, L. Lange, J. Junker, K. Lohmann, C. Klein (Lübeck, Germany)
Mechanical Ventilation Modifies the Natural History of DCTN1 p.G71A Perry Disease: A 20-Year Longitudinal Study

Y. Tsuboi, T. Mishima, A. Kakimoto, J. Yuasa-Kawada, M. Kinoshita-Kawada, H. Shibayama, A. Nagatoshi, N. Sasagasako, N. Hattori (Tokyo, Japan)
Mechanisms of PLA2G6 Deficiency Impacting Mitochondria-associated membranes in Parkinson’s Disease

JB. Liu, BS. Tang, JQ. Tan, JF. Guo (Changsha, China)
Mechanistic study of PARP9-mediated mitochondrial transfer in regulating dopaminergic neuronal injury and neuroinflammation in Parkinson’s disease

L. Liao, Z. Zhang (Guangzhou, Guangdong Province, China)
Medical Management of Late-stage Parkinson’s Disease – a Cross-sectional, Multinational Survey

C. Pallauf, C. Weck, C. Brandl, S. Lorenzl (Salzburg, Austria)
Medication Burden and Associated Challenges for People with Parkinson’s: A Survey of 359 UK Patients

S. Jones, D. van Wamelen, S. Chapman, J. Patel (London, United Kingdom)
Menstrual Cycle Influence on Parkinson’s Disease Symptoms in Women with Early-Onset

E. Bagdasarova, D. Larina, I. Zdorovec, A. Shekhvatova, K. Nazarova, M. Nikolaeva, I. Miliukhina, A. Murtazina, E. Bril, O. Turgunkhujaev (Moscow, Russian Federation)
Metabolic Brain Pattern and Longitudinal Progression in GBA-Associated Parkinson’s Disease Revealed by 18F-FDG PET/CT

PH. Li, J. Wang, ZY. Qi, XN. Liang, YX. Zhang, FT. Liu, JJ. Wu, J. Wang, CT. Zuo, YM. Sun (Shanghai, China)
Metabolic Frailty Shows Limited Predictive Insights into Motor Severity and Progression in Parkinson’s Disease Beyond Lifestyle and Cardiometabolic Determinants

M. Mijnsbergen, R. Weijer, L. Kuijer, J. van Hilten, J. Deelen, D. Hepp (Leiden, Netherlands)
Metabolic Syndrome and Disease Severity in Parkinson’s Disease: Association With Clinical Phenotype and Cerebral Small Vessel Disease

N. Başpınar, D. Türkoğlu, G. Yüksel (Istanbul, Turkey)
Metabolic Syndrome is not Associated with Parkinson’s Disease Severity, but Individual Metabolic Components May Be

TLD. Denicol, MPF. Felippe, GGA. Dal Alba, CMD. Dagostini, JSL. León, AH. Hilbig, CMR. Rieder (Porto Alegre, Brazil)
Metabolic-Structural Patterns Across Progressive Supranuclear Palsy Clinical Variants: a Multimodal PET-MRI Study

V. Maciel, M. de Oliveira, G. Martins, C. Carneiro, P. Barbosa, C. Buchpiguel, E. Barbosa, A. Coutinho, J. Parmera (São Paulo, Brazil)
Metabolomic profile as a biomarker of non-motor symptoms severity in patients with Parkinson’s disease

K. Aguiar, A. Carioca, I. Santos, F. Rolim, A. Ferreira Gomes, AS. Lima Verde, C. Figueiredo, F. Carvalho (Fortaleza, Brazil)
Methamphetamine: An Underrecognized Cause of Acute Chorea – A Case Report and Literature Review

C. Kanchanawuttitham, J. Jitprapaikulsan, YP. Pitakpatapee (Bangkok, Thailand)
Methanol Intoxication Presenting as a Mixed Ataxic-Parkinsonian Syndrome With a Paradoxical Response to Levodopa: A Case Report

D. Solorzano Gomez (Huánuco, Peru)
Micro- and Nanoplastics in Parkinson’s Disease Pathogenesis An Emerging Environmental Risk Factor

A. Aralbayeva, Z. Akhmetzhanova, A. Baidarbekova (Astana, Kazakhstan)
Microglial Inflammatory Signaling Mediates Neuroimmune Dysregulation And Behavioral Dysfunction in A Parkinson’s Disease Model

M. M. Anwar, I. Ibrahim Laila (Cairo, Egypt)
Micrographia in Parkinson’s Disease and Multiple System Atrophy: A Quantitative Tablet-Based Handwriting Study

Y. Hagiwara, J. Shin, S. Kobayashi (Tokyo, Japan)
Micrographia is an Early Abnormality in CAR-T Cell Therapy-Associated ICANS

J. Patino, S. Marcucci, K. Duque, M. Chirra, A. Suppa, A. Espay, A. Zabeti, E. Faber, L. Marsili (Cincinnati, USA)
Microsaccade Alterations and Clinical Correlates in Parkinson’s Disease

T. Soumala, P. Tsitsi, Y. Wang, M. Nilsson, P. Svenningsson, I. Markaki (Stockholm, Sweden)
Microstructural and functional abnormalities of Amygdala subregions in Parkinson’s Disease with impulse control disorder

C. Gan, Y. Yuan (Nanjing, China)
Microstructural Correlates of Parkinson’s Bradykinesia

R. Benabderrazik, S. Jasaityte, C. Dore, N. Smith, G. Sheehan, C. Lambert (London, United Kingdom)
Microstructural cortical alterations are related to cognitive and disease severity in progressive supranuclear palsy

C. Garcia Vicente, J. Pardo, C. Martín-Barceló, I. Roura, C. Falcon, R. Sala-Llonch, A. Campabadal, N. Bargalló, O. Brengaret, C. Brenlla, C. Painous, A. Cámara, M. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)
Microstructure predicts cognition after Neurostimulation in Parkinson’s disease

L. Chen, L. Witt, A. Calvano, M. Boop, C. Nimsky, H. Dafsari, L. Timmermann, M. Belke, D. Pedrosa, P. Loehrer (Marburg, Germany)
Midbrain Hypometabolism in Idiopathic REM Sleep Behavior Disorder Detected by [18F]-FDG PET as a Potential Biomarker of Nigral degeneration

A. Below, M. Ruppert-Junck, T. van Eimeren, L. Timmermann, A. Drzezga, A. Janzen, W. Oertel, D. Pedrosa (Cologne, Germany)
Midbrain Organoid Modeling and Transcriptomic Characterization of NOTCH2NLC GGC Repeat Expansion–Associated Parkinson’s Disease

H. Qian, Y. Chen, W. Wei (Hangzhou, China)
Mild Motor Impairments in Rapid Eye Movement Behavior Disorder: Tremor and Bradykinesia

JH. Lee, ER. Tobin, EA. Christou, XY. Lou, M. Louis, LH. Le, MF. Presti, MS. Jaffee, DE. Vaillancourt (Gainesville, USA)
Mild Parkinsonian Signs in Prodromal Parkinson’s Disease

YH. Nah, R. Chen, S. Ng, R. Hoe, E. Tan, Z. Xu, L. Tan (Singapore, Singapore)
Military-related associations with Parkinson’s disease (PD) in the Millenium Cohort Study

S. Goldman, E. Richard, R. Rull, E. Boyko, K. Friedl, E. Hu, L. Liu, S. Boparai, N. Riedel, K. Comyns, E. Brown, C. Tanner (San Francisco, USA)
Mirrored-Self Misidentification Expands the Neuropsychiatric Spectrum of Corticobasal Syndrome

T. Gonçalves, K. Alves, B. Sampaio, L. Berchielli, R. Pinto, S. Silva (São Paulo, Brazil)
Mitochondrial Density Shapes Regional Vulnerability to Atrophy in Parkinson’s Disease

A. Konuri, L. Churchill, J. Anderson, A. Ignatavicius, G. Halliday, R. Landin-Romero, S. Lewis, E. Matar (Sydney, Australia)
MLR–cerebellar network in body-first vs. brain-first PD: functional connectivity and clinical correlation with gait impairment

J. Jin, Z. Zong, S. Si, S. She, W. Wang, P. Pan (Wuhan, China)
Mobility Impairment And Balance Perception Discrepancy In Parkinson’s Disease

E. Isadora, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)
MobilityAPP: A randomized-controlled trial evaluating  gait-focused physiotherapy in Parkinson’s disease and  atypical parkinsonian syndromes

V. Sidoroff, C. Raccagni, H. Moradi, G. Prigent, F. Jagusch, I. Teckenburg, M. Giraitis, E. Schoenfeldt Reichmann, J. Ndayisaba, G. Göbel, K. Seppi, F. Krismer, D. Benninger, J. Winkler, B. Eskofier, J. Klucken, K. Aminian, A. Ionescu, S. Sapienza, H. Gaßner (Bolzano, Italy)
Modeling disease progression in spinocerebellar ataxias

J. Faber, E. Georgii, T. Klockgether, T. Ashizawa, K. Sheng-Han, H. Jacobi, M. Piraud (Bonn, Germany)
Modeling Parkinson’s Disease Progression to Quantify Long-Term Treatment Effects via the Concept of ‘Time Saved’

B. Ribba, T. Nikolcheva, P. Pierrillas, C. Diack, A. Monnet, B. Ricci, M. May, G. Pagano, G. Kerchner, P. Brundin (Basel, Switzerland)
Modeling the Genetic Complexity of Parkinson’s Disease: Generation of Patient-Specific iPSCs with Co-occurring SNCA/GBA1 and PRKN/LRRK2 Variants

L. Murillo-Hernández, M. Bonilla-Toribio, D. Buiza-Rueda, P. Gomez-Garre, L. Muñoz-Delgado, P. Mir, R. Mejías, A. Fontán-Lozano (Sevilla, Spain)
Modifiers of Intergenerational Repeat Changes in X-linked Dystonia–Parkinsonism

N. Endaya, S. Algodon, M. Brand, B. Laabs, R. Rosales, R. Jamora, C. Diesta, G. Saranza, N. Brüggemann, C. Klein, A. Westenberger (Lübeck, Germany)
Modulated functional connectivity in patients with Parkinson’s disease by transcutaneous auricular acupoint Vagus Nerve Stimulation (taVNS)

XJ. Dan, SS. Gao, JL. Fang, P. Chan (45#Changchun Street, Xicheng District, Beijing, China)
Modulation and subcortical signatures of sleep in Parkinson’s Disease under chronic STN-DBS: insights from Synchronized Deep Brain Sensing and nocturnal videopolysomnography

L. Baldelli, I. D'Ascanio, I. Cani, P. Mantovani, L. Palmerini, M. Pegoli, C P. Picciano, F. Mignani, C. Pazzaglia, M. Sala, P. Cortelli, L. Chiari, A. Conti, F. Provini, G. Calandra-Buonaura, G. Giannini (Bologna, Italy)
Modulation of Excitatory/Inhibitory Neurotransmission via Targeting GABAA-Gephyrin Signaling: Integrated In-Silico, In-Vitro, and In-Vivo Evidence in Parkinson’s Disease Models

S. Chib (Bathinda, India)
Modulation of Finely Tuned Gamma in the Globus Pallidus Internus with Deep Brain Stimulation and Levodopa

Z. Lajoie, J. Cagle, J. Bartfield, A. Madamangalam, D. Vuddandam, K. Johnson, J. Wong, C. de Hemptinne (Gainesville, USA)
Modulatory effects of bacterial-derived serine protease on pathological α-synuclein fibrillation in vitro

HJ. Yang, JI. Choi (Incheon, Republic of Korea)
Molecular Profiling of Brain-Derived Extracellular Vesicles and Fluid Biomarkers in Parkinsonism: Distinct Signatures and Clinical Correlates in Progressive Supranuclear Palsy

A. Roy, S. Brahmachari, A. Pantelyat, L. Rosenthal, V. Dawson, T. Dawson (Baltimore, USA)
Monitoring Levodopa Responsiveness in Parkinson’s disease using wearable sensors: the digital levodopa challenge

A. Rizzardi, A. Bonito, C. Zatti, N. Agostini, A. Magliozzi, G. Foresti, K. Eshja, C. Hansen, R. Romijnders, W. Maetzler, A. Pilotto, A. Padovani (Brescia, Italy)
Monitoring of Motor Complications with Wearable Technology in Parkinson’s Patients Considered for Deep Brain Stimulation

JC. Romero-Fábrega, L. Muñoz Delgado, E. Muñoz Campo, F. Carrillo García, B. Fernández-Rodríguez, R. Rashid-López, R. Espinosa-Rosso, L. García-Trujillo, CJ. Madrid Navarro, T. Muñoz-Ruiz, D. Rodríguez-Martín, B. Oliver Martos, P. Serrano Castro, JJ. González-Rosa, P. Mir, F. Escamilla Sevilla (Granada, Spain)
Monocyte and T-cell Immunological Profiles of Asian LRRK2 Variants G2385R And R1628P in Parkinson’s Disease: Associations with Clinical Measures

NJ. Zulkefli, NJ. Zulkefli, NS. Zulhaimi, HX. Ding, TS. Toh, JW. Hor, YW. Tay, AN. Khairul Anuar, JL. Lim, JW. Goh, RY. Ong, QH. Yong, A. Ahmad Annuar, LC. Lit, SY. Lim, R. Rajasuriar, AH. Tan (Kuala Lumpur, Malaysia)
Monogenic Parkinson’s Disease Australia (MonoPDAus) Project Update

SF. Siow, V. Flores-Ocampo, K. Weiss, WY. Yau, S. Koks, G. Mellick, H. Morales-Briceno, S. Tisch, C. Wools, J. O'Sullivan, T. Kimber, R. Wilcox, K. Wu, D. Schofield, A. Willis, C. Klein, C. Sue, MA. Young, M. Renteria, K. Kumar (Darlinghurst, Australia)
Monopolar Sensing within the Globus Pallidus and the Relationship between Clinical Outcomes and Anatomy

M. Case, C. Zarns, A. Singh, R. Vigh, A. Holt-Becker, R. Raike, A. Ragothaman, J. Lee, G. Harker, L. Neilson, K. Burchiel, M. Mancini, D. Safarpour (Minneapolis, USA)
Mood Motor Interactions in Parkinson Disease Clinical Associations and Neurobiological Mechanisms

G. Mathew, T. Rogan, O. Nikas, M. Hayes (Boston, USA)
Morvan Syndrome Associated with Malignant Thymoma and Double-Positive CASPR2/LGI1 Antibodies

K-P. Lee, C-C. Lee, J-Y. Li (Kaohsiung, Taiwan)
Motion-Capture features associated with Outcome after MRgFUS Vim thalamotomy for Essential Tremor

Y. Osakada, H. Hirabayashi, A. Kinoshita, H. Ohnishi, H. Ohnishi, R. Morihara, H. Ishiura (Okayama, Japan)
Motor and Non-motor Outcomes of Globus Pallidus internus Deep Brain Stimulation for Dystonia

V. S Rangan, V. Bharath, V. Yerramneni, S. Yareeda (Hyderabad, India)
Motor and Non-Motor Symptoms Across Psychiatric Profiles in Parkinson’s: A Cluster Analysis

R. Trejo-Ayala, H. Trujillo-Guerra, R. Enriquez-Menchaca, A. Trejo-Ayala, B. Chávez-Luévanos, X. Ortiz-Jiménez, I. Estrada-Bellmann (Monterrey, Mexico)
Motor and Quality‑of‑Life Outcomes After MR‑Guided Focused Ultrasound Subthalamotomy for Parkinson’s Disease: A Meta‑analysis

A. Achuthaprasad, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)
Motor Fluctuations and Dyskinesias in LRRK2-Associated Parkinson’s Disease

A. Agrebaoui, R. Zouari, A. Mousli, F. Nabli, D. Ben Mohamed, A. Rachdi, MZ. Saied, S. Ben Sassi (Tunis, Tunisia)
Motor Frailty Index (MFI) as an Early Predictor of Functional Progression in Parkinson’s Disease: A Longitudinal Analysis

O. Esquivel-Zapata, M. Velasco -Delgado, A. Beltrán-Torres, N. Sánchez-Lorenzo, C. Abad-Tinajero, D. Nafate-Wences, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)
Motor Network Neurophysiological (TMS-EEG) Markers as Predictors of Long-Term Outcomes Following Ventriculoperitoneal Shunt in Normal Pressure Hydrocephalus

T. Davidy, A. Suminski, Y. Zauberman, T. Fay-Karmon, S. Anis, A. Saar, N. Zifman, H. Fogel, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)
Motor outcomes and safety of staged bilateral MR-guided focused ultrasound subthalamotomy in Parkinson disease

E. Navarro-Mocholí, R. Conde-Sardón, M. Campins-Romeu, I. Sastre-Bataller, M. Losada-López, C. Morata-Martínez, MJ. Ibáñez-Julià, MN. Afkir-Ortega, A. Lozano, A. Gutiérrez-Martín, I. Martínez-Torres (Valencia, Spain)
Motor Trajectory in Parkinson’s Disease With Excessive Daytime Sleepiness: A Longitudinal Cohort Study

K. Aoshima, S. Ueno, N. Nishikawa, H. Iwaki, E. Igami, H. Takeshige(amano), T. Hatano, N. Hattori (Bunkyoku, Japan)
Motor variability in isolated and probable REM sleep behaviour disorder using remote finger tapping

H. Chohan, S. Water, L. Pérez-Carbonell, G. Leschziner, T. Periñán, B. Huxford, S. Eriksson, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)
Move-Brain-PD: a Randomized Multicenter Protocol of Remotely Monitored Home-based Aerobic Exercise for Parkinson’s Disease Patients with Mild Cognitive Impairment

AT. Cimmino, G. Di Lazzaro, D. Genovese, VL. Marian, IF. Ivan, RM. Scheytt, AR. Bentivoglio, TF. Outeiro, C. Falup-Pecurariu, P. Calabresi (Goettingen, Germany)
Movement decoding from subthalamic nucleus during deep brain stimulation surgery

J. Li, J. Olson, C. Gonzalez, C. Hurt, M. Wade, H. Walker (Birmingham, USA)
Movement Disorder Phenotypes and Etiological Associations in Genetic Early-Onset Ataxias: A Pediatric Cohort Study

F. Dridi, H. Klaa, M. Ben Hafsa, Z. Miladi, T. Ben Younes, A. Zioudi, M. Jamoussi, H. Benrhouma, I. Kraoua (Tunis, Tunisia)
Movement Disorder Phenotypes in Neuronal Antibody–Mediated Autoimmune Encephalitis

N. Nasrkhani*, N. Tahsin*, D. Dash (Limerick, Ireland)
Movement Disorder Spectrum and Neurological Outcomes in Children with Neuronal Ceroid Lipofuscinosis

A. Saini, S. Vaidya (chandigarh, India)
Movement Disorders as an Atypical Presentation of Alzheimer’s Disease: A Cerebrospinal Fluid Biomarker-Based Study

F. Rolim, C. Botelho, R. Custódio, C. Regadas, C. Cavalcante, B. Iepsen, F. Carvalho, N. Frota (Fortaleza, Brazil)
Movement Disorders Associated with Infections in Immunocompromised Non-HIV Patients: A Systematic Review

J. Sánchez-León, M. Parra Alvarez, I. Da-Silva-Gomes, T. Schlickmann, T. Luise Denicol, C. Matte Dagostini, D. Teixeira-Dos-Santos, A. Schumacher Schuh (Porto Alegre, Brazil)
Movement Neurophysiology Studies: Clinical Practice Patterns and Standardization

M. Callister, K. Longardner, T. Grippe, C. Stephen, P. Kassavetis, D. Haubenberger, J. Caviness, R. Chen, B. Klassen (Boston, USA)
MT200605 for Huntington’s Disease: Nonclinical finding and Phase I Clinical Result

L. Yongzhen, W. Ying, W. Xiangling, W. Xiaobing, W. Linyuan, W. Ruiling, H. Zhian, W. Bing (XIAN, China)
Multi-ancestry analysis of POLG variants in Parkinson’s disease

YW. Tay, I. Elsayed, D. Yeow, M. James, S. Rowe, PJ. Kong, L. Screven, H. Chen, A. Dilliott, R. Alcalay, ZH. Fang, AH. Tan, C. Sue, L. Lange, T. Perinan (Kuala Lumpur, Malaysia)
Multi-Ancestry Analysis of Repeat Expansions in Parkinson’s Disease

L. Lange, C. Cerquera-Cleves, A. Tan, S. Lim, N. Okubadejo, C. Lin, P. Chen, J. Shin, A. Ahmad-Annuar, C. Klein, H. Leonard, N. Mencacci, M. Nalls, H. Morris, K. Lohmann, C. Blauwendraat, P. Heutink, Z. Fang (Luebeck, Germany)
Multi-Modal Profiling of Peripheral and Central Nervous System T Cells Identifies Cytotoxic α-Synuclein-Reactive Immunity in Multiple System Atrophy

JS. Moon, S. Moutusy, M. Zhang, A. Ndayisaba, D. Rodriguez, M. Miglis, V. Khurana, F. Jahanbani, W. Robinson (Stanford, USA)
Multi-omic, Multi-polygenic Score Prediction of Parkinson’s disease

L. Gilchrist, S. Calhas, S. Jasaityte, O. Pain, GP2. Genetics Program, A. Noyce, K. Brolin, M. Periñan, P. Proitsi (London, United Kingdom)
Multi-Omics Analysis Reveals Brain and Biofluid Molecular Changes Induced by Chronic Sleep Fragmentation in a Prodromal Parkinson’s Disease Mouse Model

H. Yagihara, M. Miyazaki, K. Ueda, H. Yamakado, E. Minakawa (Tokyo, Japan)
Multi-Omics Biomarker Discovery in Friedreich’s Ataxia Cardiomyopathy

F. Siddiqui, T. Keller, C. Koehring, G. Upadhyay, B. Higgins, T. Zesiewicz, K. Kim, G. Halade, A. Patel, T. Mcdonald (Tampa, USA)
Multi-Sequence MRI-Based Machine Learning Model for Differentiating Parkinson Disease (PD) from Multiple System Atrophy (MSA)

Y. Wang, N. He, M. Haacke, F. Yan, G. Yang, P. Lewitt (Shanghai, China)
Multi-target Deep Brain Stimulation for Dystonia and Complex tremor syndromes: A Single-Centre Case Series and Literature Review

A. Shiramba, J. Panicker, D. Bhargava, J. Osman Farah, A. Macerollo (Liverpool, United Kingdom)
Multi-Target Neurobiological Mechanisms of Acupuncture in Levodopa-Induced Dyskinesia: From Dopamine Stabilization to Network Plasticity Modulation

X. Liu, YT. Wang, JQ. Fan, MY. Yan, YX. Wu, SM. Lin, YF. Zhang, LX. Zhuang (Guangzhou, China)
Multi-tracer positron emission tomography reveals early disruption of cerebrospinal fluid clearance in Huntington’s disease

A. Calvano, F. Turkheimer, M. Veronese, M. Moretto, H. Tang, A. Wood, S. Williams, D. van Wamelen, J. Schubert (London, United Kingdom)
Multicenter Evaluation of Automated Structural MRI-based Diagnosis for Multiple System Atrophy

K. Kawabata, H. Takeshige-Amano, T. Hatano, T. Baba, A. Takeda, S. Kuwabara, A. Ogura, M. Katsuno, R. Hanajima, M. Matsushima, I. Yabe, M. Hatakeyama, O. Onodera, H. Watanabe (Tokyo, Japan)
Multidimensional Motor Dysfunction in Early Parkinsons Disease With Turning Velocity as a Sensitive Staging Biomarker

P. Liu, J. Wu (Tianjin, China)
Multidisciplinary Care Preserves Function and Quality of Life After Nursing Home Placement in Late-Stage Parkinson’s Disease: A Prospective Cohort Study

Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku, K. Oku, T. Ito, M. Yoshimura, J. Hirata, F. Hyodo, N. Tsujiuchi, M. Mitsuishi, M. Kurokawa, D. Kimura, T. Yasuda, M. Mihara (Okayama, Japan)
Multidisciplinary Day-Clinic Treatment for Functional Movement Disorders Embedded in a Movement Disorders Center

P. Krause, J. Reimer, N. Darcy, J. Achtzehn, K. Bereswill, A. Kühn (Berlin, Germany)
Multilevel Structure-Function Coupling Reveals Network Signatures of Remission in Paroxysmal Kinesigenic Dyskinesia

XJ. Huang, Y. Li, K. Fang, ZY. Li, YS. Lv, SY. Feng, L. Cao, Y. Li, Y. Guan (Shanghai, China)
Multilingual Smartphone Application for Objective Motor Assessment in Parkinson Disease: Cross-Sectional Clinical Validation Study

B. Biswas, S. Pal, K. Das, D. Santra, D. Mukherjee, R. Gayen, H. Kumar, S. Choudhury (Kolkata, India)
Multimodal Deep Learning for Parkinson’s Disease Screening: Fusing Quantitative Gait Analysis and Clinical Features

XR. Bai, J. Xu, XY. Liu, HM. Cao (Xi'an, Shaanxi Province, China)
Multimodal Elastography-Assisted Quantitative Evaluation Tool for Diagnosing Rigidity in Parkinson’s Disease

J. Zhao, S. Ma, Z. Wan, C. Shi (Beijing, China)
Multimodal Gait Analysis Using Video Pose Estimation Deep Learning and Walkway Parameters: Parkinsonism Detection and Phenotyping

YS. Kim, JH. Yoon, RW. Park, DG. Park (Suwon, Republic of Korea)
Multimodal Imaging in Cervical Dystonia with Botulinum Toxin Treatment: A Pilot 5.0T MRI and 99mTc-MIBI SPECT/CT Study

J. Li, L. Wang, X. Song, L. He, Y. Wang, J. Li, Y. Liu, S. Li, K. Li (Beijing, China)
Multimodal Immune Biomarkers of Parkinson’s Disease Progression

A. Friend, K. Scott, A. Peattie, L. Spindler, T. Fryer, Y. Hong, C. Williams-Gray (Cambridge, United Kingdom)
Multimodal Information Exploration for Automated Clinical Scale Prediction in Neurodegenerative Diseases

N. Bozetine, M. Wójcik-Pędziwiatr, M. Baran, J. Stępień, J. Krzywdziak, W. Szecówka, M. żbik, M. Dudek, J. Sikora, D. Hemmerling, M. Rudzińska-Bar (Warsow, Poland)
Multimodal Quantitative MRI Improves Parkinson’s Disease Classification

P. González-Méndez, N. Castillo-Triana, C. Juri, M. Andia (Santiago, Chile)
Multiple System Atrophy Without Dysautonomia

I. Wilkens, V. Ruf, Y. Compta, C. Troakes, J. Cohen, E. Lee, C. Nilsson, E. Englund, J. Levin, A. Pantelyat, J. Seemiller, S. Berger, J. van Swieten, E. Dopper, A. Rozemuller, G. Kovacs, N. Bendahan, A. Lang, G. Höglinger, F. Hopfner (Munich, Germany)
Multiple System Atrophy-India (MSA-IND) Registry

N. Kumar, J. Ganguly, H. Kumar, D. Garg, S. Desai, P. Wadia, P. Lk, R. Mridula, D. Joshi, A. Reddy, S. Mehta, C. Sankhla, R. Borgohain (Hyderabad, India)
Multiplexed Serum Biomarkers for Differentiating the Parkinson’s Disease Continuum and Disease Severity

MS. Kim, IH. Kwak, JK. Yu, H. Ma, K. Choi, J. Kim, H. Hwang, YE. Kim (Hwaseong, Republic of Korea)
Multisite high-definition gamma-tACS combined with rhythmic auditory cued gait enhances network efficiency in patients with Parkinson’s disease

L. Avanzino, A. Botta, V. Romano, J. Nonnekes, M. Gilat, I. Maidan, A. Mirelman, E. Pelosin (Genoa, Italy)
Multivariate Cognitive Markers of Dementia Progression in Parkinson’s Disease

SY. Kang, SH. Lee, M. Song, MS. Kim, YE. Kim, HI. Ma, Y. Kang (Hwaseong, Republic of Korea)
Muscarinic receptor antagonism beyond M4 is required for efficacy in a preclinical model of dystonia and Parkinson’s disease

M. Rogge, J. Thornton, T. Engber, S. Engel, J. Dunn (Cambridge, USA)
Music as Therapy: A KAP Analysis of Music Therapy for Parkinson’s Disease in India

M. Udupa, P. Kukkle, S. Jaiganesh (Bangalore, India)
Mutation screening of Miro1 and Miro2 in Parkinson’s disease

J. Lin, C. Li, D. Pang, R. Ou, Q. Wei, Y. Xiao, T. Yang, Y. Gao, S. Wang, Q. Jiang, J. Liu, Y. Tan, J. Huang, Y. Ma, W. Song, X. Chen, B. Zhao, J. Yang, Y. Cui, H. Shang (Chengdu, China)
Myoclonic Tremor and Cervical Dystonia as an Atypical Presentation of Ataxia-Telangiectasia

MN. Afkir Ortega, E. Navarro Mocholi, M. Campins Romeu, I. Martinez Torres, C. Sanchis Llopis, C. Morata Martinez, J. Perez Garcia, I. Sastre Bataller (Valencia, Spain)
Myoclonus-Dystonia as a Phenotype of HGPPS1: A Case Report

S. Munasipova, Z. Zalyalova, M. Gayazov (Kazan, Russian Federation)
myParkinson’s Wellbeing Programme for people newly diagnosed and their care-partners

R. Lewis-Morton, B. Mohamed, J. Adenwalla, O. Batterbee, C. Bowsher-Murray, S. Mahon, T. Williams, C. Thomas, S. Page (Cardiff, United Kingdom)